The present invention is related to benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.
本发明涉及公式(I)的
苯并咪唑化合物,具有
大麻素受体激动作用,包括这些化合物的制药组合物、制备这些化合物的
化学过程以及它们在治疗与动物中的
大麻素受体介导的疾病,特别是人类中的应用。